Cite
HARVARD Citation
Cutland, C. et al. (2023). A phase 3, randomized, controlled, open-label study to evaluate the persistence up to 5 years of 1 or 2 doses of meningococcal conjugate vaccine MenACWY-TT given with or without 13-valent pneumococcal conjugate vaccine in 12–14-month-old children. Vaccine. 41 (5), pp. 1153-1160. [Online].